Krystal Biotech, Inc.
KRYS
$306.29
-$10.01-3.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 225.03M | 204.83M | 198.91M | 146.73M | 123.96M |
| Total Depreciation and Amortization | 2.51M | 2.42M | 2.11M | 2.13M | 3.11M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.54M | 30.04M | 26.76M | 52.05M | 50.73M |
| Change in Net Operating Assets | -7.80M | -36.42M | -51.58M | -5.51M | -39.29M |
| Cash from Operations | 250.28M | 200.87M | 176.20M | 195.40M | 138.50M |
| Capital Expenditure | -12.90M | -11.95M | -10.61M | -9.96M | -9.18M |
| Sale of Property, Plant, and Equipment | 0.00 | 435.00K | 435.00K | 435.00K | 435.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -54.34M | -46.90M | -143.18M | -173.88M | -183.48M |
| Cash from Investing | -67.23M | -58.42M | -153.36M | -183.40M | -192.23M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 27.70M | 22.66M | 9.40M | 9.05M | 17.89M |
| Repurchase of Common Stock | -16.99M | -13.96M | -13.93M | -13.93M | -13.93M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.71M | 8.71M | -4.53M | -4.88M | 3.97M |
| Foreign Exchange rate Adjustments | -1.22M | 286.00K | 329.00K | 922.00K | -474.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 192.54M | 151.44M | 18.64M | 8.04M | -50.24M |